Haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine Side Effects
Medically reviewed by Drugs.com. Last updated on Oct 23, 2022.
Applies to haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine: intramuscular powder for injection.
Nervous system
Very common (10% or more): Drowsiness
Postmarketing reports: Febrile seizures, hypotonia, headache, dizziness[Ref]
Other
Very common (10% or more): Fever (rectal 38C or higher)
Uncommon (0.1% to 1%): Fever (rectal over 39.5C)
Rare (less than 0.1%): Malaise[Ref]
Metabolic
Very common (10% or more): Decreased appetite[Ref]
Local
Very common (10% or more): Injection site reaction (swelling, pain, redness)
Common (1% to 10%): Injection site reactions including induration and nodules[Ref]
Psychiatric
Very common (10% or more): Irritability
Uncommon (0.1% to 1%): Crying
Rare (less than 0.1%): Insomnia[Ref]
Respiratory
Postmarketing reports: Apnea in very premature infants (28 weeks gestation or less)[Ref]
Gastrointestinal
Uncommon (0.1% to 1%): Diarrhea, vomiting
Rare (less than 0.1%): Abdominal pain[Ref]
Dermatologic
Uncommon (0.1% to 1%): Atopic dermatitis, rash[Ref]
Hematologic
Postmarketing reports: Lymphadenopathy[Ref]
Hypersensitivity
Postmarketing reports: Allergic reactions (including urticaria and anaphylactoid reactions)[Ref]
More about haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
Patient resources
Other brands
Related treatment guides
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
